Browsing Tag
AI in pharma
7 posts
Can Genesis Molecular AI leap ahead in biotech with Meta’s Llama leader now onboard?
Genesis Molecular AI hires Meta's Llama leader Sergey Edunov to lead foundation models. Discover how this move strengthens its AI drug discovery platform.
AstraZeneca (LSE: AZN) goes big on U.S. supply chain with latest $2bn manufacturing push
AstraZeneca invests $2B in Maryland to expand biologics and rare disease drug manufacturing. Find out what this means for U.S. jobs and the pharma supply chain.
Can AI fix peptide drug development’s biggest bottlenecks—permeability and stability?
AI is transforming peptide drug design by tackling stability and permeability challenges. Find out how platforms like Atombeat are changing the rules.
Can Atombeat and BioDuro’s trillion-compound AI engine transform peptide drug discovery in 2025?
Find out how Atombeat and BioDuro are using AI to revolutionize peptide drug discovery with faster timelines and lower R&D costs.
Cortex spotlight: Can Indegene’s AI engine become the backbone of regulatory tech automation?
Can Cortex become the platform that powers AI-led compliance automation in pharma? Explore how Indegene is building vertical AI for regulatory tech.
FPT advances digital healthcare strategy in Vietnam with AI-led public-private model
FPT Corporation launches AI-driven PPP framework to transform Vietnam’s healthcare system, aligning with Vision 2045 goals and digital health policy targets.
CytoReason secures $80m investment to expand disease modeling technologies
In a significant boost for the field of computational disease modeling, CytoReason announced an $80 million investment led…